BR0215037A - Compound, pharmaceutical composition, and use of a compound - Google Patents

Compound, pharmaceutical composition, and use of a compound

Info

Publication number
BR0215037A
BR0215037A BR0215037-9A BR0215037A BR0215037A BR 0215037 A BR0215037 A BR 0215037A BR 0215037 A BR0215037 A BR 0215037A BR 0215037 A BR0215037 A BR 0215037A
Authority
BR
Brazil
Prior art keywords
compound
pharmaceutical composition
compounds
antagonists
formula
Prior art date
Application number
BR0215037-9A
Other languages
Portuguese (pt)
Inventor
Jan Kehler
Anders Poulsen
Berith Bjornholm
Friedrich Kroll
Morten Bang Norgaard
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Priority claimed from PCT/DK2002/000858 external-priority patent/WO2003051869A1/en
Publication of BR0215037A publication Critical patent/BR0215037A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"COMPOSTO, COMPOSIçãO FARMACêUTICA, E, USO DE UM COMPOSTO". A presente invenção refere-se aos novos compostos de fórmula na qual os grupos variáveis são como definidos nas reivindicações ou a um sal de adição de ácido farmaceuticamente aceitável dos mesmos. Os compostos da invenção são antagonistas de NK2."COMPOUND, PHARMACEUTICAL COMPOSITION, AND USE OF A COMPOUND". The present invention relates to novel compounds of formula wherein the variable groups are as defined in the claims or to a pharmaceutically acceptable acid addition salt thereof. The compounds of the invention are NK2 antagonists.

BR0215037-9A 2001-12-19 2002-12-16 Compound, pharmaceutical composition, and use of a compound BR0215037A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101916 2001-12-19
PCT/DK2002/000858 WO2003051869A1 (en) 2001-12-19 2002-12-16 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives

Publications (1)

Publication Number Publication Date
BR0215037A true BR0215037A (en) 2004-12-14

Family

ID=33547527

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0215037-9A BR0215037A (en) 2001-12-19 2002-12-16 Compound, pharmaceutical composition, and use of a compound

Country Status (8)

Country Link
KR (1) KR20040068306A (en)
AR (1) AR037855A1 (en)
BR (1) BR0215037A (en)
CO (1) CO5601017A2 (en)
IS (1) IS7299A (en)
PL (1) PL371851A1 (en)
UA (1) UA81755C2 (en)
ZA (1) ZA200404333B (en)

Also Published As

Publication number Publication date
KR20040068306A (en) 2004-07-30
PL371851A1 (en) 2005-06-27
ZA200404333B (en) 2005-06-02
AR037855A1 (en) 2004-12-09
CO5601017A2 (en) 2006-01-31
IS7299A (en) 2004-06-03
UA81755C2 (en) 2008-02-11

Similar Documents

Publication Publication Date Title
BR0108678A (en) New compounds
BR0017026A (en) Lipeptides as antibacterial agents
BRPI0412291A (en) nka / nk3 dual antagonists for the treatment of schizophrenia
BR9911488A (en) Compound, use of it, pharmaceutical composition, and processes for the treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound
BRPI0108395B8 (en) pyrrolopyrimidinone derivatives, preparation and use processes
BRPI0112986B8 (en) azabicyclic compounds, process for their preparation, as well as pharmaceutical compositions comprising said compounds
BRPI0116237B8 (en) "sulfamide compound, pharmaceutical composition containing it and its use as an endothelin receptor antagonist drug".
BRPI0113162B8 (en) non-imidazole aryloxyalkylamine compounds and pharmaceutical composition comprising said compounds
BRPI0109200B8 (en) compounds and pharmaceutical compositions
ATE212978T1 (en) PARA-SUBSTITUTED PHENYLPROPANE ACID DERIVATIVES AS INTEGRIN ANTAGONISTS
BR9910573A (en) Antipicornoviral compounds, preparation and use thereof
BG66085B1 (en) Phenylalanine derivatives
BR9911482A (en) Compound, pharmaceutical composition, use of the compound, and, processes for the treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound
BR0208489A (en) N- (Arylsulfonyl) beta-amino acid derivatives having a substituted aminoethyl group, their preparation process and the pharmaceutical compositions containing them
BR0017028A (en) Lipopeptides as antibacterial agents
TR200102338T2 (en) Cyclic substituted linked pyrolocarbazoles and isoindolones.
BRPI0406801A (en) Thieno-pyrimidinedione derivatives and their use in modulating autoimmune diseases
SE9904508D0 (en) New compounds
BRPI0414514A (en) use of a compound, compound, and pharmaceutical compositions
BR0210028A (en) Antibacterial agents
BR0310077A (en) New compounds and their use
BR0206595A (en) Compound, pharmaceutical composition, and use of a compound
ATE377602T1 (en) MORPHINAN DERIVATIVES AND THEIR MEDICAL APPLICATIONS
BR0011831A (en) Compounds, process for preparing them, pharmaceutical compositions, and, use of compounds
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE 7A. E 8A. ANUIDADE(S).

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2108 DE 31/05/2011.